The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bipolar Disorder Therapeutic Market Research Report 2025
Synopsis
Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. According to Pfizer, Inc., bipolar disorder affects over 5 million people in the U.S. Bipolar episodes are characterized by a drastic change in behavior and mood, and range from joyful and overexcited (manic episodes) to extremely sad and hopeless (depressive state). These disorders have different types of episodes such as manic episodes, hypomanic episodes, depressive episodes, and mixed episodes. Causes of bipolar disorders include childhood trauma, stressful life events, self-esteem problems, and genetic inheritance. People across the world marked “March 30” as a World Bipolar Day to spread awareness about the disorder and erase the stigma of mental illness. Large number of people suffering from this mental condition resort to drinking to lift their mood. According to the National Institute on Alcohol Abuse and Alcoholism, 27.6% of the people with bipolar disorder become addicted to alcohol, while over 16% engaged in alcohol abuse.
The global Bipolar Disorder Therapeutic market was valued at US$ 3855.3 million in 2023 and is anticipated to reach US$ 4443.3 million by 2030, witnessing a CAGR of 2.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bipolar Disorder Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bipolar Disorder Therapeutic.
Report Scope
The Bipolar Disorder Therapeutic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bipolar Disorder Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bipolar Disorder Therapeutic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Allergan
Astellas Pharma
GlaxoSmithKline
Janssen Pharmaceuticals
Segment by Type
Antipsychotics
Anticonvulsants
Mood Stabilizers
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bipolar Disorder Therapeutic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bipolar Disorder Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. According to Pfizer, Inc., bipolar disorder affects over 5 million people in the U.S. Bipolar episodes are characterized by a drastic change in behavior and mood, and range from joyful and overexcited (manic episodes) to extremely sad and hopeless (depressive state). These disorders have different types of episodes such as manic episodes, hypomanic episodes, depressive episodes, and mixed episodes. Causes of bipolar disorders include childhood trauma, stressful life events, self-esteem problems, and genetic inheritance. People across the world marked “March 30” as a World Bipolar Day to spread awareness about the disorder and erase the stigma of mental illness. Large number of people suffering from this mental condition resort to drinking to lift their mood. According to the National Institute on Alcohol Abuse and Alcoholism, 27.6% of the people with bipolar disorder become addicted to alcohol, while over 16% engaged in alcohol abuse.
The global Bipolar Disorder Therapeutic market was valued at US$ 3855.3 million in 2023 and is anticipated to reach US$ 4443.3 million by 2030, witnessing a CAGR of 2.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bipolar Disorder Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bipolar Disorder Therapeutic.
Report Scope
The Bipolar Disorder Therapeutic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bipolar Disorder Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bipolar Disorder Therapeutic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Allergan
Astellas Pharma
GlaxoSmithKline
Janssen Pharmaceuticals
Segment by Type
Antipsychotics
Anticonvulsants
Mood Stabilizers
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bipolar Disorder Therapeutic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bipolar Disorder Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Bipolar Disorder Therapeutic Market Overview
1.1 Product Overview and Scope of Bipolar Disorder Therapeutic
1.2 Bipolar Disorder Therapeutic Segment by Type
1.2.1 Global Bipolar Disorder Therapeutic Market Value Comparison by Type (2024-2030)
1.2.2 Antipsychotics
1.2.3 Anticonvulsants
1.2.4 Mood Stabilizers
1.3 Bipolar Disorder Therapeutic Segment by Application
1.3.1 Global Bipolar Disorder Therapeutic Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Bipolar Disorder Therapeutic Market Size Estimates and Forecasts
1.4.1 Global Bipolar Disorder Therapeutic Revenue 2019-2030
1.4.2 Global Bipolar Disorder Therapeutic Sales 2019-2030
1.4.3 Global Bipolar Disorder Therapeutic Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bipolar Disorder Therapeutic Market Competition by Manufacturers
2.1 Global Bipolar Disorder Therapeutic Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bipolar Disorder Therapeutic Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bipolar Disorder Therapeutic Average Price by Manufacturers (2019-2024)
2.4 Global Bipolar Disorder Therapeutic Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bipolar Disorder Therapeutic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bipolar Disorder Therapeutic, Product Type & Application
2.7 Bipolar Disorder Therapeutic Market Competitive Situation and Trends
2.7.1 Bipolar Disorder Therapeutic Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bipolar Disorder Therapeutic Players Market Share by Revenue
2.7.3 Global Bipolar Disorder Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bipolar Disorder Therapeutic Retrospective Market Scenario by Region
3.1 Global Bipolar Disorder Therapeutic Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bipolar Disorder Therapeutic Global Bipolar Disorder Therapeutic Sales by Region: 2019-2030
3.2.1 Global Bipolar Disorder Therapeutic Sales by Region: 2019-2024
3.2.2 Global Bipolar Disorder Therapeutic Sales by Region: 2025-2030
3.3 Global Bipolar Disorder Therapeutic Global Bipolar Disorder Therapeutic Revenue by Region: 2019-2030
3.3.1 Global Bipolar Disorder Therapeutic Revenue by Region: 2019-2024
3.3.2 Global Bipolar Disorder Therapeutic Revenue by Region: 2025-2030
3.4 North America Bipolar Disorder Therapeutic Market Facts & Figures by Country
3.4.1 North America Bipolar Disorder Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bipolar Disorder Therapeutic Sales by Country (2019-2030)
3.4.3 North America Bipolar Disorder Therapeutic Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bipolar Disorder Therapeutic Market Facts & Figures by Country
3.5.1 Europe Bipolar Disorder Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bipolar Disorder Therapeutic Sales by Country (2019-2030)
3.5.3 Europe Bipolar Disorder Therapeutic Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bipolar Disorder Therapeutic Market Facts & Figures by Country
3.6.1 Asia Pacific Bipolar Disorder Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bipolar Disorder Therapeutic Sales by Country (2019-2030)
3.6.3 Asia Pacific Bipolar Disorder Therapeutic Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bipolar Disorder Therapeutic Market Facts & Figures by Country
3.7.1 Latin America Bipolar Disorder Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bipolar Disorder Therapeutic Sales by Country (2019-2030)
3.7.3 Latin America Bipolar Disorder Therapeutic Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bipolar Disorder Therapeutic Market Facts & Figures by Country
3.8.1 Middle East and Africa Bipolar Disorder Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bipolar Disorder Therapeutic Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bipolar Disorder Therapeutic Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Bipolar Disorder Therapeutic Sales by Type (2019-2030)
4.1.1 Global Bipolar Disorder Therapeutic Sales by Type (2019-2024)
4.1.2 Global Bipolar Disorder Therapeutic Sales by Type (2025-2030)
4.1.3 Global Bipolar Disorder Therapeutic Sales Market Share by Type (2019-2030)
4.2 Global Bipolar Disorder Therapeutic Revenue by Type (2019-2030)
4.2.1 Global Bipolar Disorder Therapeutic Revenue by Type (2019-2024)
4.2.2 Global Bipolar Disorder Therapeutic Revenue by Type (2025-2030)
4.2.3 Global Bipolar Disorder Therapeutic Revenue Market Share by Type (2019-2030)
4.3 Global Bipolar Disorder Therapeutic Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bipolar Disorder Therapeutic Sales by Application (2019-2030)
5.1.1 Global Bipolar Disorder Therapeutic Sales by Application (2019-2024)
5.1.2 Global Bipolar Disorder Therapeutic Sales by Application (2025-2030)
5.1.3 Global Bipolar Disorder Therapeutic Sales Market Share by Application (2019-2030)
5.2 Global Bipolar Disorder Therapeutic Revenue by Application (2019-2030)
5.2.1 Global Bipolar Disorder Therapeutic Revenue by Application (2019-2024)
5.2.2 Global Bipolar Disorder Therapeutic Revenue by Application (2025-2030)
5.2.3 Global Bipolar Disorder Therapeutic Revenue Market Share by Application (2019-2030)
5.3 Global Bipolar Disorder Therapeutic Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly Bipolar Disorder Therapeutic Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Corporation Information
6.2.2 Bristol-Myers Squibb Description and Business Overview
6.2.3 Bristol-Myers Squibb Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bristol-Myers Squibb Bipolar Disorder Therapeutic Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Bipolar Disorder Therapeutic Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Corporation Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allergan Bipolar Disorder Therapeutic Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 Astellas Pharma
6.5.1 Astellas Pharma Corporation Information
6.5.2 Astellas Pharma Description and Business Overview
6.5.3 Astellas Pharma Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Astellas Pharma Bipolar Disorder Therapeutic Product Portfolio
6.5.5 Astellas Pharma Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GlaxoSmithKline Bipolar Disorder Therapeutic Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Janssen Pharmaceuticals
6.6.1 Janssen Pharmaceuticals Corporation Information
6.6.2 Janssen Pharmaceuticals Description and Business Overview
6.6.3 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Product Portfolio
6.7.5 Janssen Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bipolar Disorder Therapeutic Industry Chain Analysis
7.2 Bipolar Disorder Therapeutic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bipolar Disorder Therapeutic Production Mode & Process
7.4 Bipolar Disorder Therapeutic Sales and Marketing
7.4.1 Bipolar Disorder Therapeutic Sales Channels
7.4.2 Bipolar Disorder Therapeutic Distributors
7.5 Bipolar Disorder Therapeutic Customers
8 Bipolar Disorder Therapeutic Market Dynamics
8.1 Bipolar Disorder Therapeutic Industry Trends
8.2 Bipolar Disorder Therapeutic Market Drivers
8.3 Bipolar Disorder Therapeutic Market Challenges
8.4 Bipolar Disorder Therapeutic Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
